Clinical Trials
21 trialsNCT04670445 2023-10-23
UPLIFT
Massachusetts General Hospital
Phase NA Unknown
NCT06010277 2023-08-24
FLEX
Amphia Hospital
Phase 4 Unknown
NCT04631731 2023-06-01
ICEMELT
Western Sydney Local Health District
Phase 1/2 Unknown
NCT04940637 2023-05-12
UNITO-001
University of Turin, Italy
Phase 2 Unknown
NCT05228795 2022-02-08
Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung
Sohag University
Unknown
NCT05193006 2022-01-14
Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma
Hospices Civils de Lyon
Unknown
NCT04804410 2021-03-18
Dielectric Properties of Matched Tissue Samples From Thoracic Malignancies and Corresponding Normal Tissues
University of Maryland, Baltimore
Phase NA Unknown
NCT04489862 2020-07-28
αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1 Unknown
NCT02040272 2019-10-30
MARS2
Royal Brompton & Harefield NHS Foundation Trust
Phase NA Unknown
NCT02349958 2019-04-16
HIPEC/IPHC
Bay Area Gynecology Oncology
Phase 2 Unknown
NCT02758587 2018-03-19
Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)
NHS Greater Glasgow and Clyde
Phase 1/2 Unknown
NCT02761863 2018-02-23
Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma
Ain Shams University
Unknown
NCT02395679 2015-03-23
MesoCancerVa
Erasmus Medical Center
Phase 1 Unknown
NCT01912547 2015-01-30
Thromboelastography During Surgery for Malignant Pleural Mesothelioma
Brigham and Women's Hospital
Unknown
NCT01569919 2013-03-12
SKOPOS
Wales Cancer Trials Unit
Phase 2 Unknown
NCT01719068 2012-11-01
Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos
British Columbia Cancer Agency
Unknown
NCT00996385 2011-10-31
Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma
Columbia University
Phase 2 Unknown
NCT01281800 2011-01-24
AGILI
Institute of Oncology Ljubljana
Phase 2 Unknown
NCT00794859 2009-08-04
SMS
King's College London
Phase 2 Unknown
NCT00454519 2009-02-13
IPHC
Wuhan University
Phase 2 Unknown
NCT00551252 2007-10-30
A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma
Gruppo Italiano MEsotelioma
Phase 2 Unknown